The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.